Intravenous immunoglobulin (IVIG)
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Intravenous immunoglobulin (IVIG) and local guidelines before prescribing.
Mechanism
Pooled human IgG providing passive immunity and immunomodulation.
Uses
Primary immunodeficiency, ITP, Guillain-Barre syndrome, Kawasaki disease, CIDP, myasthenic crisis.
Dosing
- IVIg 1 g/kg (repeat the next day).
Haematology: Emergencies - IVIg 1 g/kg | ITP with severe bleeding; catastrophic APS; VITT.
Haematology: Emergencies - Prednisolone 1 mg/kg or dexamethasone 40 mg for 4 days; IVIg if bleeding significantly.
Haematology: Haemostasis and Thrombosis - IVIG 2 g/kg and aspirin; steroids if high risk.
Paediatrics: Infections in children
3 more dose entries from the chapters
- Treatment - IV aciclovir 10 mg/kg every 8 hours (adjusted for kidney function) started immediately on suspicion - don't wait for CT, LP or PCR; usually 14–21 days for confirmed HSV encephalitis; hydrate well; treat seizures; immunotherapy (steroids, IVIG, plasma exchange, rituximab) for autoimmune encephalitis.
ID: Sepsis, fever and serious bacterial infections - Guillain–Barré syndrome | Ascending symmetrical weakness, areflexia , after infection (Campylobacter); back pain, autonomic instability | FVC monitoring (ICU if under 20 mL/kg or falling); IVIG or plasma exchange
Acute Medicine: Reduced consciousness, seizures, headache and acute confusion - High-dose IVIG (immunomodulation, 2 g/kg over 2–5 days) - ITP, Guillain–Barré, CIDP, multifocal motor neuropathy, Kawasaki disease, myasthenic crisis, dermatomyositis, autoimmune encephalitis - NHS England commissioning criteria apply.
Clinical Immunology: Autoimmunity, autoantibodies and complement
Side effects
Headache, infusion reactions, aseptic meningitis, thrombosis, renal impairment, haemolysis.
Interactions
Live vaccines blunted for months.
Contraindications and cautions
IgA deficiency with anti-IgA antibodies
Monitoring
Renal function, BP, infusion rate
Pregnancy and breastfeeding
Safe
Renal and hepatic impairment
Use slow infusion in renal impairment
Overdose and reversal
Supportive
Special advice
Infuse slowly; hydrate; check IgA deficiency; thrombosis and renal risk in older patients.
More from the textbook: uses, cautions and other points
- First line: IV methylprednisolone, IVIg and/or plasma exchange.
Neurology: Multiple Sclerosis and inflammatory disease - Attacks: IV methylprednisolone, then a slow oral steroid taper (relapses often occur when steroids are reduced quickly); plasma exchange or IVIg if severe.
Neurology: Multiple Sclerosis and inflammatory disease - Relapsing disease: maintenance IVIg , azathioprine, mycophenolate or rituximab. Newer targeted drugs are in development.
Neurology: Multiple Sclerosis and inflammatory disease - Treatment: IV methylprednisolone, then an oral taper; IVIg or plasma exchange if no response.
Neurology: Multiple Sclerosis and inflammatory disease - IVIg / plasma exchange | Severe attacks of NMOSD, MOGAD, myelitis; autoimmune encephalitis.
Neurology: Multiple Sclerosis and inflammatory disease - Treatment: Treat the cancer - the most important step. Add immunotherapy (steroids, IVIg, plasma exchange, rituximab); syndromes with antibodies to intracellular targets (Hu, Yo) respond poorly.
Neurology: Oncology and Hydrocephalus - IVIg , steroids or plasma exchange .
Neurology: Neuromuscular disease - Maintenance IVIg or subcutaneous immunoglobulin.
Neurology: Neuromuscular disease
Where it is discussed in the book
- Neurology: Multiple Sclerosis and inflammatory disease (5 mentions)
- Neurology: Oncology and Hydrocephalus (1 mention)
- Neurology: Neuromuscular disease (10 mentions)
- Renal: Dialysis and Transplant (4 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Emergencies (6 mentions)
- Haematology: Anaemia (1 mention)
- Haematology: Haemoglobinopathies and Transfusion (2 mentions)
- Haematology: Haemostasis and Thrombosis (7 mentions)
- Oncology: Emergencies (1 mention)
- Paediatrics: Neonatology (2 mentions)
- Paediatrics: Infections in children (8 mentions)
- Dermatology: Skin infections and infestations (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (3 mentions)
- Rheumatology: Connective tissue diseases (5 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (9 mentions)
- ENT: Common Nose and Throat disorders (1 mention)
- ID: Sepsis, fever and serious bacterial infections (5 mentions)
- ID: Viral, fungal and parasitic infections (1 mention)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (3 mentions)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Clinical Immunology: Primary immunodeficiency (2 mentions)
- Clinical Immunology: Autoimmunity, autoantibodies and complement (5 mentions)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (3 mentions)
- Critical care: common problems, ethics and recovery (1 mention)
- Integrated paediatrics chapter (10 mentions)
- Pathology: Immunopathology, amyloidosis, genetic and environmental disease (1 mention)